Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Investing Activities: 2010-2024

Historic Cash from Investing Activities for CorMedix (CRMD) over the last 13 years, with Dec 2024 value amounting to $21.2 million.

  • CorMedix's Cash from Investing Activities fell 4708.50% to -$291.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$312.0 million, marking a year-over-year decrease of 4656.48%. This contributed to the annual value of $21.2 million for FY2024, which is 224.44% up from last year.
  • According to the latest figures from FY2024, CorMedix's Cash from Investing Activities is $21.2 million, which was up 224.44% from -$17.1 million recorded in FY2023.
  • In the past 5 years, CorMedix's Cash from Investing Activities registered a high of $21.2 million during FY2024, and its lowest value of -$17.1 million during FY2023.
  • For the 3-year period, CorMedix's Cash from Investing Activities averaged around $153,221, with its median value being -$3.7 million (2022).
  • Per our database at Business Quant, CorMedix's Cash from Investing Activities slumped by 359.96% in 2023 and then soared by 224.44% in 2024.
  • CorMedix's Cash from Investing Activities (Yearly) stood at $7.4 million in 2020, then crashed by 223.01% to -$9.1 million in 2021, then spiked by 59.39% to -$3.7 million in 2022, then crashed by 359.96% to -$17.1 million in 2023, then skyrocketed by 224.44% to $21.2 million in 2024.